Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics 2021-01-07 21:20
Dr David Stamler Appointed CEO 2021-01-07 21:00
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies 2021-01-07 20:31
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain 2021-01-07 20:00
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China 2021-01-07 18:45
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics 2021-01-07 17:00
Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer 2021-01-06 21:54
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer 2021-01-06 21:52
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding 2021-01-06 21:25
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18 2021-01-06 21:00
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease 2021-01-06 20:24
JOYSBIO's COVID-19 antigen test kit is capable of detecting the new SARS-COV-2 strain found in the United Kingdom and the United States 2021-01-06 15:11
TurtleTree Labs, the global leader in cell based milk, launches TurtleTree Scientific 2021-01-06 06:00
Global Cord Blood Announces NHC Policy Update 2021-01-05 20:30
Y-Biologics signed License Agreement with 3D Medicines for T cell bispecific engager in Greater China territory 2021-01-05 09:00
Ascentage Pharma Announces its 9th Orphan Drug Designation from the US FDA in 2020, Setting a Record for Chinese Biopharmaceutical Companies 2021-01-05 08:32
Antengene Announces Submission of IND Application in China for a Global Phase 3 Trial of ATG-010 (Selinexor) in Advanced or Recurrent Endometrial Cancer 2021-01-05 08:00
AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics' Newly Approved Libmeldy(TM) 2021-01-04 22:30
PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021" 2021-01-04 21:00
Happiness Biotech Announces Registered Direct Offering of up to 4.2 Million Ordinary Shares to Strategic Investors 2021-01-04 21:00